Active

    Veeda Clinical Research Limited

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Veeda Clinical Research Limited IPO Details

    Listing Date

    -

    Bid Price

    ₹0 - ₹0

    Lot Size

    0 Shares

    Minimum Investment

    Issue Size

    ₹0 Cr

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    -

    tick

    Offer End Date

    -

    tick

    Allotment Date

    -

    tick

    Refund Initiation

    -

    tick

    Demat Transfer

    -

    tick

    Listing Date

    -

    Veeda Clinical Research Limited Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 0% 0%
    Public Group 100% 100%

    Veeda Clinical Research Limited IPO Reservation

    QIB Shares Offered 0 (0%)
    NII (HNI) Shares Offered 0 (0%)
    Retail Shares Offered 0 (0%)
    Anchor Investor Shares Offered 0 (0%)
    Total Shares Offered 0
    Total Shares With Anchor Investor 0

    Veeda Clinical Research Limited IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) [-] [-] ₹[-]
    Retail (Max) [-] [-] ₹[-]
    S HNI (Min) [-] [-] ₹[-]
    S HNI (Max) [-] [-] ₹[-]
    B HNI (MIN) [-] [-] ₹[-]

    Veeda Clinical Research Limited IPO registrar

    MUFG Intime India Pvt Ltd
    Phone Number + 91 81081 14949
    Email Id Veedalifesciences.ipo@linkintime.co.in
    Website https://in.mpms.mufg.com

    Veeda Clinical Research Limited IPO Lead Manager

    1. Axis Capital Ltd

    2. CLSA India Pvt ltd

    3. IIFL Capital Services Ltd

    4. SBI Capital Markets Ltd

    Veeda Clinical Research Limited Financial Information

    March 31, 2025 March 31, 2024 March 31, 2023
    Net Worth ₹855.76 Cr ₹1,059.97 Cr ₹457.16 Cr
    Reserves and Surplus ₹842.6 Cr ₹1,047.37 Cr ₹446.58 Cr
    Total Borrowing ₹405.97 Cr ₹261.68 Cr ₹48.57 Cr

    Strength of Veeda Clinical Research Limited

    • A platform for drug development needs of customers.
    • Successful integration of growth opportunities through acquisitions.
    • Strong scientific capabilities across business services.
    • Established quality credentials with a strong focus on quality control management.
    • Global and diverse management team with deep scientific expertise.

    Risks Involved

    • The company derives a significant portion of its revenue from contracts with the company top clients. Its top five clients contributed more than 41.16% of the company revenue from contract with customers in the six months period ended September 30, 2024 with its top client that contributed approximately 28.37% of the company revenue from contract with customers in the six months period ended September 30, 2024. Loss of any of these clients could adversely affect its business, results of operations, cash flows and financial condition.
    • The potential loss or delay under any of its large contracts or of multiple key client contracts could adversely affect the company financial results specifically since the relationship of backlog to revenues varies over time and may not be fully realisable in the event of contract cancellation.
    • The company required to perform its services in accordance with contractual requirements, regulatory standards in applicable jurisdictions and ethical considerations. Any adverse action by any authority, including the Food and Drug Administration or the European Medicines Agency against it would negatively impact on the company ability to offer its services to the company clients and adversely impact its business and prospects.
    • If the company fails to deliver services in accordance with contractual requirements, the company could be subject to significant costs or liability and its reputation could be harmed.
    • The company has incurred losses for the six months period ended September 30, 2024 and Financial Year 2024 and may continue to do so in the future, which may adversely impact its business and the value of the Equity Shares.
    • The company financial performance is dependent on the company ability to secure business from clients in the pharmaceutical and biopharmaceutical industry. Consequently, any adverse changes in outsourcing trends in the pharmaceutical and biopharmaceutical industry and changes in aggregate spending and research and development budgets could adversely affect its operating results and growth rate.
    • The company studies and clinical trials could subject it to potential liability that may adversely affect its business, results of operations, cash flows and financial condition.
    • The company may not derives the anticipated benefits from its strategic investments and acquisitions, including the company acquisition of Heads and its may not be successful in pursuing future investments and acquisitions.
    • Failures to maintain confidential information of the company clients could adversely affect its business, results of operations, cash flows and financial condition and/or reputation.
    • The company is subject to risks arising from interest rate which could adversely affect its business, results of operations, cash flows and financial condition.
    stock
    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    SOTEFIN BHARAT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    16th Jul 2026 - 7th Jul 2026
    Price Range
    ₹178.0 - 187.0
    IPO Size
    ₹89,76,00,000
    Bidding Period
    17th Jul 2026 - 7th Jul 2026
    Price Range
    ₹402.0 - 424.0
    IPO Size
    ₹4,49,99,99,744
    GULF LLOYDS INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    20th Jul 2026 - 7th Jul 2026
    Price Range
    ₹100.0 - 100.0
    IPO Size
    ₹18,19,00,000
    • All
    • MainBoard
    • SME
    Metalic Technoforge Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Jul 2026 - 7th Jul 2026
    Price Range
    ₹72.0 - 77.0
    IPO Size
    ₹49,96,00,000
    Cube Highways Trust IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    22nd Jul 2026 - 7th Jul 2026
    Price Range
    ₹151.0 - 152.0
    IPO Size
    ₹49,99,99,98,976
    Bidding Period
    22nd Jul 2026 - 7th Jul 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹18,90,00,000
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AceVector Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Annu Projects Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AOne Steels India Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    APPL Containers Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ardee Engineering Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    ALPINE TEXWORLD LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹100.0 - 105.0
    IPO Size
    ₹1,26,24,99,968
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹315.0 - 331.0
    IPO Size
    ₹1,60,33,99,936
    SBI FUNDS MANAGEMENT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹545.0 - 574.0
    IPO Size
    ₹98,12,91,00,800
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹203.0 - 214.0
    IPO Size
    ₹7,42,00,00,256
    DEVSON CATALYST LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹42,34,00,000
    HAPPY STEELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹62.0 - 66.0
    IPO Size
    ₹25,08,00,000
    KUSUMGAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    8th Jul 2026 - 7th Jul 2026
    Price Range
    ₹398.0 - 419.0
    IPO Size
    ₹6,49,99,99,744
    Bidding Period
    3rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹94.0 - 99.0
    IPO Size
    ₹47,91,00,000
    KNACK PACKAGING LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    1st Jul 2026 - 7th Jul 2026
    Price Range
    ₹161.0 - 170.0
    IPO Size
    ₹4,39,49,99,808
    KRATIKAL TECH LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹128.0 - 135.0
    IPO Size
    ₹39,69,00,000
    SEEMAX RESOURCES LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹134.0 - 141.0
    IPO Size
    ₹19,74,00,000
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹80.0 - 84.0
    IPO Size
    ₹27,22,00,000
    ATHARVA POLYPLAST LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹55.0 - 60.0
    IPO Size
    ₹27,00,00,000
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹220.0 - 220.0
    IPO Size
    ₹37,36,00,000
    VINIT MOBILE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹150.0 - 158.0
    IPO Size
    ₹34,13,00,000
    TWINKLE PAPERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    29th Jun 2026 - 7th Jul 2026
    Price Range
    ₹64.0 - 69.0
    IPO Size
    ₹28,00,00,000
    Bidding Period
    29th Jun 2026 - 7th Jul 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹44,03,00,000
    AASTHA SPINTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    29th Jun 2026 - 7th Jul 2026
    Price Range
    ₹125.0 - 136.0
    IPO Size
    ₹1,70,00,00,000
    Bidding Period
    25th Jun 2026 - 6th Jun 2026
    Price Range
    ₹94.0 - 99.0
    IPO Size
    ₹47,91,00,000
    CRAZY SNACKS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    25th Jun 2026 - 6th Jun 2026
    Price Range
    ₹39.0 - 42.0
    IPO Size
    ₹31,47,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    214.00
    Listing Day Close
    262.85(22.90%)
    DEVSON CATALYST LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    205.95(74.58%)
    HAPPY STEELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    66.00
    Listing Day Close
    68.50(4.55%)
    KUSUMGAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    419.00
    Listing Day Close
    604.45(44.15%)
    Issue Prize
    99.00
    Listing Day Close
    174.30(75.76%)
    KNACK PACKAGING LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    170.00
    Listing Day Close
    182.70(7.65%)
    KRATIKAL TECH LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    135.00
    Listing Day Close
    182.40(34.81%)
    SEEMAX RESOURCES LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    141.00
    Listing Day Close
    107.20(-24.11%)
    Issue Prize
    84.00
    Listing Day Close
    93.45(10.71%)
    ATHARVA POLYPLAST LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    60.00
    Listing Day Close
    72.45(20.00%)
    Issue Prize
    220.00
    Listing Day Close
    438.90(99.55%)
    VINIT MOBILE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    158.00
    Listing Day Close
    147.25(-6.96%)
    Issue Prize
    70.00
    Listing Day Close
    82.16(17.14%)
    AASTHA SPINTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    136.00
    Listing Day Close
    136.45(0.00%)
    Issue Prize
    99.00
    Listing Day Close
    174.30(75.76%)
    CRAZY SNACKS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    42.00
    Listing Day Close
    45.67(9.52%)
    CSM TECHNOLOGIES LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    113.00
    Listing Day Close
    107.35(-5.31%)
    Issue Prize
    808.00
    Listing Day Close
    667.35(-17.45%)
    ADVIT JEWELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    138.00
    Listing Day Close
    178.15(28.99%)
    RIYAASAT LIFESTYLE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    106.00
    Listing Day Close
    80.60(-23.58%)

    Frequently Asked Questions

    What is Veeda Clinical Research Limited IPO?

    Answer Field

    Veeda Clinical Research Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on .

    When Veeda Clinical Research Limited IPO will open?

    Answer Field

    The Veeda Clinical Research Limited IPO opens on [-] and closes on [-].

    What is the lot size of Veeda Clinical Research Limited?

    Answer Field

    Veeda Clinical Research Limited lot size is [-] shares, and the minimum amount required is ₹[-].

    How to apply for Veeda Clinical Research Limited IPO?

    Answer Field

    You can apply in Veeda Clinical Research Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Veeda Clinical Research Limited IPO allotment?

    Answer Field

    The finalization of Basis of Allotment for Veeda Clinical Research Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

    When is Veeda Clinical Research Limited IPO listing date?

    Answer Field

    The Veeda Clinical Research Limited listing date is [-].

    Who is the registrar of Veeda Clinical Research Limited IPO?

    Answer Field

    The registrar of Veeda Clinical Research Limited IPO is MUFG Intime India Pvt Ltd

    Which company is the book-running lead manager of the IPO?

    Answer Field

    Axis Capital Ltd,CLSA India Pvt ltd,IIFL Capital Services Ltd,SBI Capital Markets Ltd will be the book-running lead manager of this IPO.

    What is the fresh issue of Veeda Clinical Research Limited IPO?

    Answer Field

    The fresh issue size is ₹[-] Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Veeda Clinical Research Limited?

    Answer Field

    Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

    How can I approve the UPI mandate request for Veeda Clinical Research Limited IPO?

    Answer Field

    To apply for Veeda Clinical Research Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Veeda Clinical Research Limited?

    Answer Field

    The price of each Veeda Clinical Research Limited share will be ranging in between ₹[-] to ₹[-] per share.

    What is the cut-off time for the UPI mandate for Veeda Clinical Research Limited IPO?

    Answer Field

    The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |